Mind Medicine Inc (NASDAQ:MNMD) shares, rose in value on Wednesday, July 09, with the stock price up by 3.35% to the previous day’s close as strong demand from buyers drove the stock to $7.72.
Actively observing the price movement in the last trading, the stock closed the session at $7.47, falling within a range of $7.56 and $7.81. The value of beta (5-year monthly) was 2.884. Referring to stock’s 52-week performance, its high was $10.44, and the low was $4.70. On the whole, MNMD has fluctuated by -0.90% over the past month.
With the market capitalization of Mind Medicine Inc currently standing at about $583.27 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-08.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MNMD’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of MNMD currently trading nearly 9.13% and 10.47% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 61.87, while the 7-day volatility ratio is showing 4.98% which for the 30-day chart, stands at 6.24%. Furthermore, Mind Medicine Inc (MNMD)’s beta value is 2.90.
A comparison of Mind Medicine Inc (MNMD) with its peers suggests the former has fared considerably weaker in the market. MNMD showed an intraday change of 3.35% in last session, and over the past year, it grew by 10.92%%.
Data on historical trading for Mind Medicine Inc (NASDAQ:MNMD) indicates that the trading volumes over the past 10 days have averaged 1.16 and over the past 3 months, they’ve averaged 1.12 million. According to company’s latest data on outstanding shares, there are 75.51 million shares outstanding.
Nearly 3.55% of Mind Medicine Inc’s shares belong to company insiders and institutional investors own 54.03% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 11.07 million shares as on 2025-06-13, resulting in a short ratio of 9.07. According to the data, the short interest in Mind Medicine Inc (MNMD) stood at 1476.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 11.5 million. The stock has risen by 9.04% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MNMD stock heading into the next quarter.
